GlassScriptPhysician profile
Lino A Ossanna
NPI 1003849514
$1,005.84
in general payments reported to CMS, 2019-2025
17 companies · $88.67 in 2025
The $88.67 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.29 · 2020: $18.50 · 2021: $84.04 · 2022: $312 · 2023: $181 · 2024: $232 · 2025: $88.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454 · Education: $25.60 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.97 |
| Education | $25.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $213.25 | 2021-2024 | |
| Abbvie INC. | $166.98 | 2019-2025 | |
| Intuitive Surgical, INC. | $115.60 | 2022-2025 | |
| Hologic Sales and Service, LLC | $95.75 | 2019-2024 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $89.56 | 2023-2024 | |
| Smith+Nephew, INC. | $63.08 | 2021-2024 | Pico 7, Pico 14 |
| Organon LLC | $47.58 | 2024 | |
| Amgen INC. | $31.36 | 2019 | |
| Biogen, INC. | $28.97 | 2024 | Zurzuvae |
| Octapharma USA, INC. | $24.52 | 2025 | Fibryga |
| Shield Therapeutics INC | $22.95 | 2023 | Accrufer |
| Aspira Women'S Health INC | $22.36 | 2024 | Ova1 |
| Therapeuticsmd, INC. | $22.08 | 2022 | |
| Exeltis, USA INC. | $18.50 | 2020 | |
| Merz North America, INC. | $15.85 | 2025 | Xeomin |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $14.33 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Minerva Surgical, INC | $13.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lino Ossanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.